Login
Israel-Hamas Conflict
Military
World Cup
Social Media
Benjamin Netanyahu
Donald Trump
Drones
Artificial Intelligence
Soccer
South America
Bitcoin
Cryptocurrency
G7
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Fidaxomicin Tied to Lower C difficile Recurrence in Immunocompromised Patients

Summary by contagionlive.com
Presented at MAD-ID 2025, Natt Patimavirujh, PharmD, supports fidaxomicin over vancomycin for high-risk groups, including transplant and chemotherapy patients.

1 Articles

All
Left
Center
Right
contagionlive.comcontagionlive.com

Fidaxomicin Tied to Lower C difficile Recurrence in Immunocompromised Patients

Presented at MAD-ID 2025, Natt Patimavirujh, PharmD, supports fidaxomicin over vancomycin for high-risk groups, including transplant and chemotherapy patients.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

contagionlive.com broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal